Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE) (STOP-HE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Ocera Therapeutics
Information provided by (Responsible Party):
Ocera Therapeutics Identifier:
First received: October 11, 2013
Last updated: October 21, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)